CurveBeam AI Limited (CVB.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.019 (-5.00%) as of
Key statistics
- Market cap
- 7.36M
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 0.0160 – 0.1300
- Beta
- 1.72
- Revenue (TTM)
- 8.67M
- Profit margin
- -217.30%
- Volume
- 931.28k
About CurveBeam AI Limited
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hatfield, PA, United States
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.